Is There a Rationale for GnRH Analogue Therapy in Endometriosis?
This paper discusses the diagnostic criteria and evaluation of medical therapy response for endometriosis, a common gynecological disease with persistent controversies in its pathogenesis and pathophysiology.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
This chapter discusses diagnostic criteria for endometriosis and how response to medical therapy should be evaluated, with the overarching aim of examining whether there is a rationale for GnRH analogue therapy. It frames endometriosis within broader controversies about its pathogenesis and pathophysiology, drawing on existing evidence and background research rather than presenting a new original patient study. A major caveat is that the work is largely conceptual and review-based, relying on criteria and prior studies without providing new controlled comparative outcome data. Relevance to endometriosis: the entire chapter is specifically about endometriosis and evaluates the rationale for GnRH analogue therapy within the context of diagnostic and treatment response assessment, so it is directly focused on endometriosis.
Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works
Full text
4,012 characters
· extracted from
oa-doi-fallback
· 3 sections
· click to expand
Abstract
References
Keywords
Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.
My notes (saved in your browser only)
Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works
Condition tags
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (13)
- Classification of endometriotic implants by morphologic appearance and capacity to synthesize prostaglandin F via openalex
- Estrogen and progestin receptors in endometriosis lesions: Comparison with endometrial tissue via openalex
- Histologic and Ultrastructural Changes in Human Endometriotic Implants Treated with the Antiprogesterone Steroid Ethylnorgestrienone (Gestrinone) During 2 Months via openalex
- Nonpigmented endometriosis: Clinical, laparoscopic, and pathologic definition via openalex
- Peritoneal endometriosis due to the menstrual dissemination of endometrial tissue into the peritoneal cavity via openalex
- The morphologic effect of short-term medical therapy of endometriosis via openalex
- Ultrastructural Changes in Endometriotic Tissue During Danazol Treatment via openalex
- W2415755045 via openalex
- W170550312 via openalex
- W1968557684 via openalex
- W2227993884 via openalex
- W2406830263 via openalex
- W73242332 via openalex
Source provenance
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00